SCHEMBL11208230

SCHEMBL11208230

O=C(NCS(=O)(=O)c1ccccc1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 1.00
ALDH1A1 P00352 3/20 0.79
TP53 P04637 1/20 0.79
TDP1 Q9NUW8 1/20 0.79
GAA P10253 2/20 0.57
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
HSD11B1 P28845 1/20 0.51
KAT6A Q92794 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
USP2 O75604 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CA2 P00918 1/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11207452 0.89 ALDH1A1 (1.00) MAPTALDH1A1TP53TDP1CYP1A2
SCHEMBL8957221 0.82 MAPT (0.69) MAPTALDH1A1TP53TDP1GAA
SCHEMBL15791835 0.82 MAPT (0.70) MAPTALDH1A1TP53TDP1CYP1A2
SCHEMBL11306682 0.82 MAPT (0.70) MAPTALDH1A1TP53TDP1HSD11B1
SCHEMBL7129375 0.81 MAPT (0.68) MAPTALDH1A1TP53TDP1GAA
SCHEMBL7927400 0.81 MAPT (0.68) MAPTALDH1A1TP53TDP1HSD11B1
SCHEMBL25285696 0.80 MAPT (0.66) MAPTALDH1A1TP53TDP1CYP1A2
SCHEMBL11084341 0.79 MAPT (0.66) MAPTALDH1A1TP53TDP1GAA
SCHEMBL1018418 0.79 MAPT (0.66) MAPTALDH1A1TP53TDP1GAA
SCHEMBL11313154 0.79 MAPT (0.66) MAPTALDH1A1TP53TDP1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176773-A1 Non-Peptidic Inhibitors of AKAP/PKA Interaction FORSCHUNGSVERBUND BERLIN E.V. (DE) 2009-07-09 US disclosed
US-20090176773-A1 Non-Peptidic Inhibitors of AKAP/PKA Interaction FORSCHUNGSVERBUND BERLIN E.V. (DE) 2009-07-09 US disclosed
EP-0017068-B1 MIXTURES CONTAINING AZODICARBON AMIDE AND ALPHA-AMIDO SULFONES, THEIR PREPARATION AND USE AS A BLOWING AGENTS BAYER AG (DE) 1983-01-12 EP disclosed
US-4280004-A ACTIVATORS BAYER AKTIENGESELLSCHAFT (DE) 1981-07-21 US disclosed
EP-0017068-A1 Mixtures containing azodicarbon amide and alpha-amido sulfones, their preparation and use as a blowing agents BAYER AG (DE) 1980-10-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176773-A1 Non-Peptidic Inhibitors of AKAP/PKA Interaction PRKCH, AIP, PRKCE MAPT 3655/4885ALDH1A1 4689/4885TP53 4474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.